6.3 Ophthalmic Electrophysiology: ERG, VEP, and EOG

Ophthalmic Electrophysiology: ERG, VEP, and EOG

Clinical visual electrophysiology provides objective, quantitative biophysical assessments of the neurosensory retina, retinal pigment epithelium (RPE), and central visual pathways. While structural imaging modalities such as Optical Coherence Tomography (OCT) and Fluorescein Angiography (FA) delineate anatomical morphology and microvascular perfusion, electrophysiology measures the functional cellular health and electrical transmission of distinct neural populations. For certified retina technicians, understanding electrophysiological protocols and diagnostic waveforms is essential for evaluating inherited retinal dystrophies, toxic retinopathies, unexplained visual loss, and retinal vascular occlusions.

---

Full-Field Flash Electroretinogram (ffERG): Cellular Origins & Waveform Kinetics

The full-field flash electroretinogram (ffERG) records the mass electrical potential generated by the entire neurosensory retina in response to brief flashes of light. When photons strike the retina, biochemical phototransduction alters membrane conductance across retinal neurons, producing transretinal ion fluxes that propagate to the cornea.

Electrode Systems

Electrical potentials are recorded in microvolts (µV) using specialized sensor arrays:

• Active Corneal Electrodes: Contact the tear film or anterior cornea. Common types include the DTL fiber electrode (a conductive silver-nylon thread placed atraumatically in the inferior conjunctival fornix, offering superior patient comfort), the Burian-Allen lens (a bipolar speculum contact lens with built-in lid retractors), and the ERG-Jet (a disposable plastic contact lens with a gold conductive ring).
• Reference & Ground Electrodes: Placed on the outer canthi (reference) and earlobe or central forehead (ground).

The Biphasic Waveform: a-Wave and b-Wave

A standard full-field flash ERG response exhibits a characteristic biphasic electrical signature:

Voltage (µV)
   ^
   |               b-wave (Depolarization of ON-bipolar & Müller cells)
   |                 /\ 
   |                /  \ 
Baseline ---------/----\-------------------------> Time (ms)
   |      \      /      \ 
   |       \____/        \ 
   |       a-wave (Hyperpolarization of Photoreceptors)
   v

1. The a-Wave (Early Negative Deflection):

   • Cellular Origin: Directly generated by the outer segments of photoreceptors (rods and cones).
   • Biophysical Mechanism: In the dark, photoreceptors maintain an inward "dark current" of sodium and calcium ions. Photon absorption activates rhodopsin, triggering a G-protein (transducin) cascade that activates phosphodiesterase (PDE), degrading cGMP. The closure of cGMP-gated cation channels halts the dark current, causing photoreceptor hyperpolarization (negative corneal deflection).

2. The b-Wave (Large Positive Deflection):

   • Cellular Origin: Post-synaptic inner retinal processing, specifically generated by depolarizing ON-bipolar cells with modulatory contributions from radial Müller glial cells.
   • Biophysical Mechanism: Photoreceptor hyperpolarization reduces glutamate release at the photoreceptor-bipolar synapse. Depolarizing ON-bipolar cells depolarize, driving an efflux of potassium ions into the extracellular space. Surrounding Müller cells buffer this potassium flux, generating a massive transretinal positive current directed toward the cornea.

3. Oscillatory Potentials (OPs):

   • Cellular Origin: Three to five high-frequency, low-amplitude wavelets perched on the ascending limb of the b-wave.
   • Mechanism: Generated by feedback microcircuits in the inner plexiform layer involving amacrine and interplexiform cells. OPs are exquisitely sensitive to capillary ischemia and disappear early in diabetic retinopathy, retinal vein occlusions, and ocular ischemic syndrome.

---

ISCEV Standard Testing Protocol for ffERG

To ensure diagnostic reproducibility worldwide, the International Society for Clinical Electrophysiology of Vision (ISCEV) defines standard stimulation and adaptation sequences. Maximally dilating both pupils is mandatory; un-dilated or asymmetrical pupils alter retinal luminance and invalidate results.

Phase 1: Dark-Adapted (Scotopic) Testing (Rods Isolated)

The patient undergoes 20 minutes of complete dark adaptation to allow full regeneration of 11-cis-retinal and maximize rod photoreceptor sensitivity:

1. Dark-Adapted 0.01 ERG (Rod Response): Evoked by an ultra-dim white flash (0.01 cd·s/m²). This stimulus is well below cone threshold, producing a pure, isolated rod-driven b-wave with no detectable a-wave.
2. Dark-Adapted 3.0 ERG (Maximal Combined Rod-Cone Response): Evoked by a standard bright flash (3.0 cd·s/m²). Stimulates both rods and cones simultaneously, producing a deep negative a-wave (mixed rod-cone) and a high-amplitude positive b-wave (normal b-wave amplitude > 350 to 500 µV; b-to-a ratio > 1.5).
3. Dark-Adapted Oscillatory Potentials: Recorded using high-pass temporal filtering (75–300 Hz) to isolate amacrine cell activity.

Phase 2: Light-Adapted (Photopic) Testing (Cones Isolated)

The patient undergoes 10 minutes of light adaptation inside a Ganzfeld dome illuminated with a steady white background luminance (30 cd/m²). This bright background completely bleaches and desensitizes rod photoreceptors, isolating cone system responses: 4. Light-Adapted 3.0 ERG (Single-Flash Cone Response): A standard flash (3.0 cd·s/m²) on the light-saturating background yields a rapid cone a-wave and b-wave, reflecting central and peripheral cone system integrity. 5. Light-Adapted 30 Hz Flicker ERG: Cones possess rapid recovery kinetics and can resolve visual stimuli up to 50–60 Hz. Rods, burdened by slow recovery, cannot track frequencies above 15 Hz and remain completely unresponsive. A 30 Hz stroboscopic flicker stimulus therefore generates a clean, sinusoidal waveform that isolates pure cone function. A delay in the timing of the flicker peaks (prolonged implicit time) is often the earliest sensitive sign of generalized cone dysfunction.

---

Hallmark Electrophysiological Signatures in Vitreoretinal Disease

---

Multifocal Electroretinography (mfERG)

Limitations of Full-Field ERG in Macular Disease

A critical clinical concept for retina technicians is that the macula represents less than 5% of the total retinal surface area. Consequently, an absolute disciform scar or dense geographic atrophy confined to the central fovea will leave the full-field flash ERG completely normal, because the remaining 95% of healthy peripheral retina overwhelms the response.

Biophysical Principles of mfERG

To assess localized macular function, Erich Sutter developed the multifocal ERG (mfERG):

• The patient fixates steadily on the center of a high-resolution display displaying an array of 61 or 103 black-and-white hexagonal elements covering the central 30 degrees of the retina.
• The hexagons oscillate between black and white according to a pseudorandom binary mathematical sequence (an m-sequence).
• Advanced cross-correlation software extracts independent, localized first-order kernel electrical responses for every individual hexagon, generating a three-dimensional topographic map of central cone activity.

Clinical Application: Hydroxychloroquine (Plaquenil) Toxicity Screening

According to the American Academy of Ophthalmology (AAO) screening guidelines, mfERG serves as a primary objective test for detecting chloroquine and hydroxychloroquine retinal toxicity:

• Hydroxychloroquine binds to melanin in the RPE and damages parafoveal photoreceptors.
• mfERG demonstrates early parafoveal cone response depression (attenuated amplitudes and prolonged implicit times in rings 2 and 3) while central foveolar ring 1 response is initially spared.
• This functional loss is detected on mfERG before structural disruption is visible on OCT and long before visible "bull's eye" maculopathy appears on fundus examination.

---

Electrooculography (EOG) & The Arden Ratio

The human eye functions as an electrical battery or dipole: the cornea maintains a positive electrical potential (+6 to +10 mV) relative to the posterior pole/retina, which is electrically negative. This constant resting voltage is the corneo-fundal standing potential.

Biophysical Origin

The standing potential is generated by the active transepithelial transport of ions across the retinal pigment epithelium (RPE), primarily maintained by chloride and sodium-potassium channels across the RPE basolateral membrane. Changes in ambient illumination modulate photoreceptor activity, which releases chemical messengers that alter RPE basolateral membrane resistance.

EOG Examination Protocol

1. Skin electrodes are adhered to the medial and lateral canthi of both eyes.
2. The patient performs continuous horizontal saccadic eye movements between two alternating red fixation lights separated by an angle of 30 degrees.
3. As the positive cornea swings toward a canthal electrode, it induces a transient voltage swing proportional to the standing potential.
4. Dark Phase (15 minutes): Ambient lights are extinguished. The standing potential steadily declines to a minimum value called the Dark Trough (DT).
5. Light Phase (15 minutes): Bright Ganzfeld illumination is initiated. The standing potential rises dramatically to a maximum peak known as the Light Peak (LP).

The Arden Ratio (Light Peak / Dark Trough)

The diagnostic metric of the EOG is the Arden Ratio: $\text{Arden Ratio} = \frac{\text{Light Peak Amplitude (}\mu\text{V)}}{\text{Dark Trough Amplitude (}\mu\text{V)}}$

• Normal Arden Ratio: $\ge 1.80$ (or $\ge 180%$).
• Equivocal / Borderline: $1.65$ to $1.79$.
• Subnormal / Severely Abnormal: $< 1.65$ (or $< 165%$).

Diagnostic Hallmark: Best Vitelliform Macular Dystrophy

Best disease (bestrophinopathy) is an autosomal dominant macular dystrophy caused by mutations in the BEST1 gene encoding bestrophin-1, a calcium-sensitive chloride channel in the RPE basolateral membrane:

• In Best disease, the EOG demonstrates a severely subnormal or completely flat Arden ratio (typically 1.10 to 1.30).
• Crucially, the full-field flash ERG remains completely normal throughout the early and middle stages of the disease.
• A markedly abnormal EOG with a relatively preserved full-field ERG is classically associated with Best vitelliform macular dystrophy, but the laboratory and clinician interpret it with phenotype and genetics.

---

Visual Evoked Potential (VEP)

While ERG and EOG evaluate retinal layers, the Visual Evoked Potential (VEP) records electrical activity generated in the primary visual cortex (striate cortex, Brodmann area 17) in response to visual stimulation, evaluating the entire retrobulbar visual pathway from the optic nerve through the chiasm and optic radiations to the occipital cortex.

Electrode Placement & Stimulation Modalities

• Electrodes are applied to the scalp according to the International 10-20 system: active electrode at the occipital pole (Oz), reference electrode at the frontal midline (Fz), and ground electrode at the vertex (Cz) or earlobe.
• Pattern-Reversal VEP: The patient fixates on a high-contrast checkerboard where black and white checks invert at a constant frequency (e.g., 2 reversals/sec). Preferred in cooperative patients; highly sensitive to conduction delays.
• Flash VEP: Uses a Ganzfeld or handheld stroboscopic flash. Administered to infants, comatose patients, or eyes with dense media opacities (dense vitreous hemorrhage, mature cataract) to assess optic nerve viability prior to vitrectomy or cataract surgery.

Waveform Components: The P100 Wave

The pattern-reversal VEP produces a triphasic complex consisting of N75 (negative at 75 ms), P100 (prominent positive peak at ~100 ms), and N135 (negative at 135 ms):

• P100 Latency (Conduction Velocity): Measures the time elapsed between the checkerboard reversal and the apex of the P100 peak (normal: $100 \pm 5\text{ ms}$). Prolongation of P100 latency (e.g., 125 to 160 ms) is the hallmark sign of demyelination of the optic nerve, classically seen in optic neuritis associated with multiple sclerosis. Latency delays often persist indefinitely even after visual acuity returns to 20/20.
• P100 Amplitude (Axonal Density): Measured from the trough of N75 to the peak of P100 (normal > 5 to 10 µV). Reduced amplitude reflects loss of functional axons, observed in compressive optic neuropathy (meningioma, pituitary adenoma), ischemic optic neuropathy, or glaucoma.
• Functional / Non-Organic Visual Loss (Malingering): A crisp, normal pattern-reversal P100 waveform with normal latency and amplitude in a patient claiming complete bilateral blindness (NLP or 20/400) provides indisputable, objective proof of intact visual pathway function.

---

Clinical Comparison of Ophthalmic Electrophysiology Modalities